BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,047 filers reported holding BAXTER INTL INC in Q4 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $569,295 | -59.2% | 15,084 | -50.7% | 0.02% | -14.8% |
| Q2 2023 | $1,393,654 | +121.9% | 30,590 | +97.5% | 0.03% | -25.0% |
| Q1 2023 | $628,129 | -60.7% | 15,486 | -50.6% | 0.04% | -28.0% |
| Q4 2022 | $1,598,536 | +47.9% | 31,362 | +56.3% | 0.05% | -46.2% |
| Q3 2022 | $1,081,000 | -29.9% | 20,064 | -16.4% | 0.09% | -27.9% |
| Q2 2022 | $1,541,000 | -21.4% | 23,999 | -5.1% | 0.13% | -6.5% |
| Q1 2022 | $1,960,000 | -9.9% | 25,281 | -0.3% | 0.14% | -11.5% |
| Q4 2021 | $2,176,000 | +7.6% | 25,352 | +0.8% | 0.16% | -10.9% |
| Q3 2021 | $2,022,000 | +94.4% | 25,143 | +94.7% | 0.18% | +90.2% |
| Q2 2021 | $1,040,000 | -4.4% | 12,917 | +0.1% | 0.09% | -17.1% |
| Q1 2021 | $1,088,000 | +5.6% | 12,906 | +0.5% | 0.11% | -7.5% |
| Q4 2020 | $1,030,000 | 0.0% | 12,837 | +0.2% | 0.12% | -16.7% |
| Q3 2020 | $1,030,000 | -8.4% | 12,811 | -1.9% | 0.14% | -19.1% |
| Q2 2020 | $1,124,000 | -4.1% | 13,054 | -3.3% | 0.18% | -18.3% |
| Q1 2020 | $1,172,000 | +14.9% | 13,493 | +12.9% | 0.22% | +4.8% |
| Q4 2019 | $1,020,000 | -2.6% | 11,954 | +0.2% | 0.21% | -15.4% |
| Q3 2019 | $1,047,000 | +7.3% | 11,936 | +0.1% | 0.25% | +7.4% |
| Q2 2019 | $976,000 | +7.4% | 11,920 | 0.0% | 0.23% | +8.5% |
| Q1 2019 | $909,000 | +8.5% | 11,920 | 0.0% | 0.21% | -1.4% |
| Q4 2018 | $838,000 | -9.0% | 11,920 | 0.0% | 0.21% | -5.7% |
| Q3 2018 | $921,000 | +4.4% | 11,920 | 0.0% | 0.23% | -14.3% |
| Q2 2018 | $882,000 | +13.5% | 11,920 | 0.0% | 0.26% | -7.3% |
| Q1 2018 | $777,000 | +0.6% | 11,920 | 0.0% | 0.29% | -0.7% |
| Q4 2017 | $772,000 | +2.9% | 11,920 | 0.0% | 0.29% | +18.5% |
| Q3 2017 | $750,000 | +3.6% | 11,920 | 0.0% | 0.24% | +53.8% |
| Q2 2017 | $724,000 | +6.9% | 11,920 | -8.5% | 0.16% | +9.7% |
| Q1 2017 | $677,000 | +2.1% | 13,022 | 0.0% | 0.14% | -0.7% |
| Q4 2016 | $663,000 | +16.9% | 13,022 | +9.2% | 0.14% | -0.7% |
| Q3 2016 | $567,000 | +24.6% | 11,920 | 0.0% | 0.15% | +15.9% |
| Q4 2015 | $455,000 | +16.1% | 11,920 | 0.0% | 0.13% | +8.6% |
| Q3 2015 | $392,000 | -53.0% | 11,920 | 0.0% | 0.12% | -47.3% |
| Q2 2015 | $834,000 | +1.1% | 11,920 | -1.0% | 0.22% | -2.7% |
| Q1 2015 | $825,000 | -4.3% | 12,045 | +1.0% | 0.23% | -8.1% |
| Q2 2014 | $862,000 | -20.3% | 11,920 | -40.6% | 0.25% | +164.5% |
| Q3 2011 | $1,081,000 | – | 20,064 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |